Harlan W R
Public Health Service, National Institutes of Health (NIH), Bethesda, MD 20892-9629, USA.
J Altern Complement Med. 2001;7 Suppl 1:S45-52. doi: 10.1089/107555301753393805.
In 1998, the National Institutes of Health (NIH) formed the National Center for Complementary and Alternative Medicine (NCCAM) from what had formerly been the Office of Alternative Medicine. This presentation opens with a brief discussion on the history of the NIH and the development of CAM at the NIH before moving on to the work of the NCCAM. The NCCAM is moving toward an integration of CAM therapies into conventional medicine, when there is evidence for the value of CAM. One of twenty-five institutes or centers at the NIH, the NCCAM looks at evidence-based medicine and public health. In this context, "public health" means educating the public about its health. The NCCAM supports training to conduct research and plays an important role in disseminating information to the public and to health providers about what works and what is safe. This evolves into the concept of evidence-based medical and public-health practices, that is, making decisions on the basis of evidence from scientifically rigorous studies that are sufficiently large to provide a confident estimate of biologically and medically important benefits and risks. In the hierarchy of generating scientific evidence, randomized controlled trials are considered the "gold standard." The NCCAM entertains proposals for studies that come spontaneously from investigators, or, upon identifying an existing need that is not being met by the investigative community, the NCCAM can initiate a request for proposals. Every proposal is subjected to a rigorous application and review process. Another possible step in the assessment of the evidence from clinical trials is to do a systematic analysis of several studies to bring together all the information that is available. Systematic reviews of smaller studies that individually might have an insufficient sample size can assist in making treatment decisions, but, importantly, they can lead the NCCAM in the development of future, definitive studies. Training to conduct research is especially important to CAM. This presentation outlines several approaches the NCCAM has to training (see http://nccam.nih.gov).
1998年,美国国立卫生研究院(NIH)在原替代医学办公室的基础上组建了国立补充与替代医学中心(NCCAM)。本报告开篇简要讨论了NIH的历史以及NIH中补充与替代医学(CAM)的发展情况,之后再转向NCCAM的工作。当有证据证明CAM疗法有价值时,NCCAM正朝着将CAM疗法整合到传统医学中的方向发展。作为NIH的25个研究所或中心之一,NCCAM关注循证医学和公共卫生。在此背景下,“公共卫生”意味着对公众进行健康教育。NCCAM支持开展研究的培训,并在向公众和医疗服务提供者传播关于哪些方法有效、哪些方法安全的信息方面发挥重要作用。这就演变成了循证医学和公共卫生实践的概念,即基于来自科学严谨研究的证据做出决策,这些研究规模足够大,能够对生物学和医学上重要的益处和风险提供可靠估计。在生成科学证据的层次结构中,随机对照试验被视为“金标准”。NCCAM会受理研究人员自发提出的研究提案,或者在确定研究界未满足的现有需求后,NCCAM可以发起提案征集。每个提案都要经过严格的申请和评审过程。评估临床试验证据的另一个可能步骤是对多项研究进行系统分析,以汇集所有可用信息。对个体样本量可能不足的较小研究进行系统综述有助于做出治疗决策,但重要的是,它们可以引导NCCAM开展未来的确定性研究。开展研究的培训对CAM尤为重要。本报告概述了NCCAM在培训方面采用的几种方法(见http://nccam.nih.gov)。